+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Wound Dressings Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033

  • PDF Icon

    Report

  • June 2023
  • Region: Global
  • GlobalData
  • ID: 5742588
Wound Dressings Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 is built to visualize quantitative market trends within Wound Care Management therapeutic area.

The model discusses in detail the impact of COVID-19 on Wound Dressings market for the year 2020 and beyond. Chronic wounds, surgical procedures, burn and trauma cases are the leading causes for treatments necessitating the use of advanced wound dressing. These dressings include moist and active traditional dressing products that are combined with drug formulations to provide enhanced healing properties. The market is expected to be driven by an increasing prevalence of diabetes and obesity, an aging population, patient awareness and a rise in hospital acquired infections.

A large number of wound dressings are available with a wide range of physical performance characteristics and costs, becoming one of the greatest prescribing challenges for physicians. Antimicrobial dressings are the key trend currently being used as an alternative to traditional dressings and systemic antibiotics. The increase in surgical procedures, burn and trauma cases will exhibit an increase in usage of advanced wound dressings. Global Data predicts that this increase in different procedures and cases will increase the demand for advanced wound dressings market.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Wound Dressings and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total Wound Dressings market revenue by segment and market outlooks from 2015-2033.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, publisher analysts provide unique country specific insights on the market.
  • SWOT analysis for Wound Dressings market.
  • Competitive dynamics insights and trends provided for Wound Dressings market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - 3M Co, B. Braun Melsungen AG, BSN Medical GmbH, Coloplast A/S, ConvaTec Group Plc, Molnlycke Health Care AB, Smith & Nephew Plc, Urgo Ltd, and Others.

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have deep understanding of the Wound Dressings marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

  • Understand the impact of COVID-19 on Wound Dressings market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Wound Dressings market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Wound Dressings market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Wound Dressings market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3M Co
  • B. Braun Melsungen AG
  • BSN Medical GmbH
  • Coloplast A/S
  • ConvaTec Group Plc
  • Molnlycke Health Care AB
  • Smith & Nephew Plc
  • Urgo Ltd